Clinical Trials Browser

Phase 3 × Cognitive Dysfunction × 90 days × Clear all

NCT05230758 2026-05-01

Met Med Can

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Phase 3 Recruiting

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction